# Navidea (NAVB) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/NAVB
## Company Profile
- Ticker: NAVB
- Exchange: AMEX
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: Not available
- Market cap: Not available
## Business Overview
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
## Why The Stock Is Moving

Current closing-price context is not available for NAVB.

## Geographic Base

Navidea is headquartered in the United States and listed on NYSE American. It sits in small-cap biotech and medical imaging-adjacent therapeutics.

## Business Model

The company depends on corporate restructuring, financing, and the ability to preserve value in a very narrow asset set. Investors historically watched regulatory developments and strategic shifts.

## Landscape Position

Navidea occupies a legacy small-cap biotech niche. The stock has long been driven more by capital structure and survival than by broad commercial scale.

## Future Catalysts

- Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.

## Recent News
- 2025-10-08 20:57 EST — [Navidea Biopharmaceuticals, Inc. Files for Bankruptcy](https://biopharmsignal.com/news/NAVB/navidea-biopharmaceuticals-inc-files-for-bankruptcy) — Source: Navidea
- 2025-05-21 18:52 EST — [Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split](https://biopharmsignal.com/news/NAVB/navidea-biopharmaceuticals-inc-announces-extension-of-authority-to-implement-a-reverse-stock-split) — Source: Navidea
- 2025-03-31 22:08 EST — [Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets](https://biopharmsignal.com/news/NAVB/navidea-biopharmaceuticals-announces-the-extension-of-plan-designed-to-protect-nols-and-other-tax-assets) — Source: Navidea
- 2024-07-03 20:30 EST — [Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024](https://biopharmsignal.com/news/NAVB/navidea-biopharmaceuticals-inc-announces-results-of-exploratory-analysis-completed-on-july-2-2024) — Source: Navidea
- 2024-06-20 22:02 EST — [Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024](https://biopharmsignal.com/news/NAVB/navidea-biopharmaceuticals-inc-announces-special-meeting-of-stockholders-to-be-held-july-8-2024) — Source: Navidea